AI assistant
DEXCOM INC — Director's Dealing 2018
Nov 14, 2018
30198_dirs_2018-11-13_b42092b7-cafa-4690-8ae1-6e5570c5ece5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2018-11-09
Reporting Person: Abbey Donald (EVP, Quality & Regulatory Afrs)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-09 | Common Stock | S | 1750 | $147.6217 | Disposed | 96889 | Direct |
| 2018-11-09 | Common Stock | S | 1900 | $148.6629 | Disposed | 94989 | Direct |
| 2018-11-09 | Common Stock | S | 6900 | $149.9075 | Disposed | 88089 | Direct |
Footnotes
F1: On September 13, 2018, Mr. Abbey adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2: This transaction was executed in multiple trades at prices ranging from $147.22 to $148.11. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected
F3: Included in this number are 70,590 restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 18,333 of which were granted on May 31, 2016 and shall vest through May 31, 2019.
F4: This transaction was executed in multiple trades at prices ranging from $148.22 to $149.01. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected
F5: This transaction was executed in multiple trades at prices ranging from $149.28 to $150.11. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected